Abiopharma

🔍 Vintz Stephen A (Director)

Company: Tenable Holdings, Inc. (TENB)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Acquired 1,595 shares of Common Stock (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 612,119.00 | transaction_form_type: 4
• Sold 764 shares of Common Stock at $33.94 per share (Direct)
  Date: 2026-08-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 611,355.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 2,345 shares of Common Stock (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 613,700.00 | transaction_form_type: 4
• Sold 1,123 shares of Common Stock at $33.94 per share (Direct)
  Date: 2026-08-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 612,577.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 6,095 shares of Common Stock (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 618,672.00 | transaction_form_type: 4
• Sold 2,917 shares of Common Stock at $33.94 per share (Direct)
  Date: 2026-08-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 615,755.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 5,095 shares of Common Stock (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 620,850.00 | transaction_form_type: 4
• Sold 2,438 shares of Common Stock at $33.94 per share (Direct)
  Date: 2026-08-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 618,412.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 7,764 shares of Common Stock (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 626,176.00 | transaction_form_type: 4
• Sold 3,716 shares of Common Stock at $33.94 per share (Direct)
  Date: 2026-08-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 622,460.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 4,519 shares of Common Stock (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 626,979.00 | transaction_form_type: 4
• Sold 2,163 shares of Common Stock at $33.94 per share (Direct)
  Date: 2026-08-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 624,816.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,595 shares of Performance Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,195.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
• Sold 2,345 shares of Performance Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 14,077.00 | transaction_form_type: 4 | Footnotes: F2, F4, F4
• Sold 6,095 shares of Performance Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 60,957.00 | transaction_form_type: 4 | Footnotes: F2, F5, F5
• Sold 5,095 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,191.00 | transaction_form_type: 4 | Footnotes: F2, F6, F6
• Sold 7,764 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 77,644.00 | transaction_form_type: 4 | Footnotes: F2, F7, F7
• Sold 4,519 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 27,114.00 | transaction_form_type: 4 | Footnotes: F2, F8, F8

Footnotes:

• F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the Restricted Stock Units ("RSUs") and does not represent a sale.
• F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
• F3: On February 21, 2024, the Compensation Committee of the Issuer's Board of Directors certified the achievement of the Performance Restricted Stock Units (PRSUs) granted on February 22, 2023 and determined a 93.9% payout for the measurement period based on the Issuer's fiscal year 2023 criteria. 25% of the shares underlying the PRSUs vested on February 22, 2024, with the remainder vesting in equal quarterly installments over 3 years, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date, and subject to accelerated vesting in specified circumstances.
• F4: On February 13, 2025, the Compensation Committee of the Issuer's Board of Directors certified the achievement of the Performance Restricted Stock Units (PRSUs) granted on February 22, 2024 and determined a 96.4% payout for the measurement period based on the Issuer's fiscal year 2024 criteria. 25% of the shares underlying the PRSUs vested on February 22, 2025, with the remainder vesting in equal quarterly installments over 3 years, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date, and subject to accelerated vesting in specified circumstances.
• F5: On February 25, 2026, the Compensation Committee of the Issuer's Board of Directors certified the achievement of the Performance Restricted Stock Units (PRSUs) granted on February 21, 2025 and determined a 97.2% payout for the measurement period based on the Issuer's fiscal year 2025 criteria. 25% of the shares underlying the PRSUs vested on February 25, 2026, with the remainder vesting in equal quarterly installments over 3 years, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date, and subject to accelerated vesting in specified circumstances.
• F6: 25% of the shares underlying the RSUs vest on February 22, 2024, with the remainder vesting in equal quarterly installments over 3 years, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date, and subject to accelerated vesting in specified circumstances.
• F7: 25% of the shares underlying the RSUs vested on August 22, 2025, 25% on February 22, 2026, with the remainder vesting in equal quarterly installments over 3 years, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date, and subject to accelerated vesting in specified circumstances.
• F8: 25% of the shares underlying the RSUs vest on February 22, 2025, with the remainder vesting in equal quarterly installments over 3 years, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date, and subject to accelerated vesting in specified circumstances.